Search
for
Sort by
Research 691–720 of 1000+
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Low Level Laser and Light Therapy
- Androgenetic alopecia—Perspective from patients in a Singaporean tertiary Dermatology center
- Androgens and Cardiovascular Disease
- Selenium for preventing cancer
- Anthralin/dithranol in dermatology
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Self-Reported Outcome After Diode Laser Hair Removal
- Controversies in the treatment of androgenetic alopecia: The history of finasteride
- The Impact of 5α-Reductase Inhibitor Use for Male Pattern Hair Loss on Men’s Health
- Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy
- The Safety of Testosterone Therapy in Women
- Modulating testosterone pathway: a new strategy to tackle male skin aging?
- Post-finasteride Syndrome: A Review of Current Literature
- Extracellular Vesicles for Androgenetic Alopecia: Current Evidence, Mechanisms, and Clinical Prospects
- Understanding Exosomes in Hair Regeneration.
- Skin Boosters: 2026 Updated
- Alternative Therapies for Hair Loss: Stem Cells, Oils, and Laser Treatment
- Finasteride: risk of suicidality and depression
- 695 Using MALDI-MSI analysis to study distribution of FOL-005, a potent, novel inhibitor of human hair growth, after subcutaneous injection in mice
- Dermatoscopic of pseudocyst of the scalp
- Thousand-graft Hair Transplantation
- High‐dose pulsed corticosteroid therapy combined with methotrexate for severe alopecia areata of childhood
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Natural history of androgenetic alopecia
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Post-Finasteride Syndrome. Literature Review
- A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor
- Gynécomastie et finastéride (Propecia®) : 4 nouveaux cas